ADR120S

ADR120S Net Margin

The Net Profit Margin of ADR120S (3750.T) as of Nov 3, 2026 is -778.43 %. In the previous year, Net Profit Margin was -1,751.24 % — a change of -55.55% (higher).

Net Margin

-778.43 %

YoY

-55.55%

Last updated:

Net Profit Margin of ADR120S is 2026 -778.43 % . Net Profit Margin of ADR120S was 2025 -1,751.24 % . It decreases by -55.55% higher compared to the previous year.

For ADR120S, the net margin of -778.4% is down versus -5.8% a few years ago.

The ADR120S Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
30.80 JPY
Jan 1, 2020
27.06 JPY
Jan 1, 2021
-59.92 JPY
Jan 1, 2022
-5.81 JPY
Jan 1, 2023
-49.42 JPY
Jan 1, 2024
8.85 JPY
Jan 1, 2025
-1,751.24 JPY
Jan 1, 2026
-778.43 JPY
The ADR120S Net Margin history
YEARNet MarginYoY
-778.43 %-55.55%
-1,751.24 %-19,879.20%
8.85 %-117.92%
-49.42 %+750.24%
-5.81 %-90.30%
-59.92 %-321.45%
27.06 %-12.14%
30.80 %-64.26%
86.16 %-599.81%
-17.24 %-1,456.15%
1.27 %-57.12%
2.96 %-65.74%
8.65 %+13,060.87%
0.07 %-259.64%
-0.04 %-120.30%
0.20 %-304.57%
-0.10 %-7.33%
-0.11 %-35.82%
-0.17 %-10.94%
-0.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADR120S Stock analysis

What does ADR120S do? ADR120S Inc generates revenue through its Real Asset segment, which involves buying and selling real estate, developing and operating hotels, and investing in real estate projects. The Medical segment focuses on regenerative medicine, selling medical equipment like the Celusion centrifuge and Celusion cell therapy kit, and providing cell therapy services. The company serves clients in real estate development, hotel operations, and healthcare sectors, with products targeting medical facilities and clinics specializing in regenerative treatments. The Real Asset segment handles property transactions, hotel management, and real estate investments, while the Medical segment offers cell therapy solutions through its branded products. Both segments target businesses seeking to expand in real estate or adopt advanced medical technologies, with the Celusion products being key revenue drivers in the healthcare market. ADR120S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADR120S stock

Net Profit Margin of ADR120S is -778.43 % in 2026.

Net Profit Margin of ADR120S changed from -1,751.24 % to -778.43 %, representing a -55.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin ADR120S since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's ADR120S with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — ADR120S

All Key Metrics — ADR120S